We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Hyperway Pharm Stock

Invest in or calculate the value of your shares in Hyperway Pharm or other pre-IPO companies through EquityZen's platform.

Get Started

Hyperway Pharm Stock

Hyperway Pharm IS A Pharmaceutical research and development production enterprise

About Hyperway Pharm Stock

Founded

2019

Industries

Software, Artificial Intelligence, Data and Analytics

Hyperway Pharm is a pharmaceutical R&D and production enterprise with R&D as the core driving force. It adheres to the philosophy of “Hai Na Baichuan, Bocai, Changzhi, Good People, and Great Deeds”, and is committed to building a world-leading research and development platform for small molecule innovative drugs and high-end APIs. Research and development platform for research and development platforms and high-tech barriers. Its core founding team is a special high-end talent in Chengdu, Sichuan Province, and has many Fortune 500 companies such as Bayer, Johnson & Johnson, Sanofi and Merck, as well as “Kingming Kant”. Work experience of domestic well-known pharmaceutical companies such as “Hengrui”, “Yangzijiang”, “Hai Cisco”, “Smart Chemical” and “Bite Pharmaceutical”, with rich experience in international and domestic drug development and management, and led the team. It has successively developed a number of world-class innovative drugs (which have entered clinical trials) and a number of high-end high-end generic drugs
Locked Features

Join now and verify your accreditation status to gain access to:

  • Hyperway Pharm Current Valuation
  • Hyperway Pharm Stock Price
  • Hyperway Pharm Management
  • Available deals in Hyperway Pharm and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Hyperway Pharm Cap Table and Funding History by Share Class and Liquidity Preferences
    • Hyperway Pharm Revenue and Financials
    • Hyperway Pharm Highlights
    • Hyperway Pharm Business Model
    • Hyperway Pharm Risk Factors
  • Hyperway Pharm Research Report from SACRA Research
Join Now

Trading Hyperway Pharm Stock

How to invest in Hyperway Pharm stock?

Accredited investors can buy pre-IPO stock in companies like Hyperway Pharm through EquityZen funds. These investments are made available by existing Hyperway Pharm shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Hyperway Pharm stock?

Shareholders can sell their Hyperway Pharm stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Hyperway Pharm